NCT07112248

Brief Summary

Obesity-related poor sperm quality is a significant public health issue, acting as a major contributor to male infertility. Dietary intervention has emerged as an effective strategy to manage obesity and improve sperm quality. Soluble dietary fiber (SDF), an essential nutritional component, plays a crucial role in regulating host health. Notably, insufficient SDF intake has been associated with both obesity and low sperm motility. However, the effect of SDF supplementation on sperm quality in males with obesity remains unclear. Thus, we conducted a randomized, placebo-controlled study to investigate the effect of SDF supplementation on sperm quality in males with obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 8, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

August 10, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2026

Completed
Last Updated

May 18, 2026

Status Verified

May 1, 2026

Enrollment Period

5 months

First QC Date

August 2, 2025

Last Update Submit

May 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The sperm quality of obese males

    The sperm quality includes the motility, concentration and morphology of sperm and these parameters are all measured by Computer-Assisted Semen Analysis.

    Baseline, 4 weeks and 12 weeks.

Secondary Outcomes (11)

  • Changes in the levels of sex hormones

    Baseline, 4 weeks, 12 weeks

  • Changes in sexual function

    Baseline, 4 weeks, 12 weeks

  • Changes in DNA integrity of sperm

    Baseline, 4 weeks, 12 weeks

  • Changes in the gut microbiota

    Baseline, 4 weeks, 12 weeks

  • Changes in the levels of bile acids in plasma

    Baseline, 4 weeks, 12 weeks

  • +6 more secondary outcomes

Study Arms (2)

Control group

PLACEBO COMPARATOR

15 g maltodextrin in a sachet once daily for 12 weeks.

Dietary Supplement: Placebo

Soluble dietary fiber group

EXPERIMENTAL

15 g inulin in a sachet once daily for 12 weeks.

Dietary Supplement: inulin

Interventions

PlaceboDIETARY_SUPPLEMENT

Maltodextrin

Control group
inulinDIETARY_SUPPLEMENT

Inulin is a kind of soluble dietary fiber.

Soluble dietary fiber group

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male, aged 18-60 years;
  • Diagnostic criteria for obesity: BMI ≥ 28 kg/m² and body fat percentage ≥ 25%;
  • Semen samples can be collected, and sperm concentration \> 0.

You may not qualify if:

  • Spermatogenic dysfunction caused by non-obesity factors;
  • Severe systemic diseases such as cardiovascular/cerebrovascular, hepatic/renal disorders, malignant tumors, uncontrolled diabetes, or thyroid diseases;
  • Recent usage of medications/supplements affecting spermatogenesis or gut microbiota ;
  • Lifestyle factors potentially impairing sperm quality or severe gastrointestinal disorders;
  • Poor compliance, planned imminent fertility, or history of bariatric surgery/weight-loss medications;
  • Significant dietary changes within the past three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hubei Maternal and Child Health Care Hospital

Wuhan, Hubei, China

Location

MeSH Terms

Interventions

Inulin

Intervention Hierarchy (Ancestors)

StarchGlucansBiopolymersPolymersMacromolecular SubstancesDietary CarbohydratesCarbohydratesFructansPolysaccharides

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

August 2, 2025

First Posted

August 8, 2025

Study Start

August 10, 2025

Primary Completion

January 4, 2026

Study Completion

January 5, 2026

Last Updated

May 18, 2026

Record last verified: 2026-05

Locations